CMR-based assessment of myocardial edema in the setting of ischemia and reperfusion
- 481 Downloads
KeywordsIschemia Cardiovascular Magnetic Resonance Late Gadolinium Enhancement Infarct Volume Myocardial Edema
Cardiovascular Magnetic Resonance (CMR) based assessments of area-at-risk and salvageable myocardium on the basis of myocardial edema in the setting of acute coronary syndrome is of significant clinical interest. However, their dependence on the choice of acquisition method and time to imaging has not been studied. In this study, we investigated the temporal evolution of myocardial edema during ischemia and reperfusion phases using both T2 maps and T2-STIR images.
Canines (n=10), subjected to I-R injury, underwent CMR (1.5T) before ischemia (baseline), during ischemia and on days 2, 5, and 7 post-reperfusion. T2-preapred SSFP (T2-preparation durations = 0, 24 and 55 ms; TR/TE = 2.2/1.1ms; BW = 1002 Hz/pixel), T2-STIR (TR = 2-3 RR intervals; TE = 64ms; TI = 170 ms; BW = 355 Hz/pixel) and Late Gadolinium Enhancement (LGE; IR-prepared SSFP; TR/TE = 3.5/1.75 ms; BW = 1002 Hz/pixel) images of the whole LV were acquired. T2 maps were constructed from T2-prepared SSFP images. Using threshold-based analysis, percentage edema volume (%Edema from both T2 maps and T2-STIR images), infarct volume (%Infarct from LGE images) and salvageable volume (%Salvage = %Edema - %Infarct) were computed relative to total LV myocardial volume.
Although ischemia led to a small but significant increase in relative myocardial edema volume, it was not indicative of post-reperfusion infarct or edema volumes. Both relative edema and salvageable myocardial volumes remained unchanged during the sub-acute period of reperfused myocardial infarction. T2 maps and T2-STIR images provided equivalent information regarding relative edema and salvageable volumes.
This work was supported in part by grants from American Heart Association (SDG 0735099N) and National Heart, Lung, And Blood Institute (HL091989).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.